Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Melodic Event: A Survey of \Energies and Exhibitions Assessed\ Live concert- Getting ready for a Mechanized World: 10 Positions That computer based intelligence Could Dominate
- Flights canceled at 40 U.S. airports: Follow live updates as FAA cuts to air traffic take effect amid government shutdown
- How grandchildren are stepping up to fill the caregiver gap
- Hostages as leverage: Iran's secret demand aimed at crippling Israel's agriculture
- Manual for Tracking down the Immaculate Magnificence of Focal Asia
- Dwayne ‘the Rock’ Johnson opens up about being the 'new guy' again — and why this moment feels like a new life
- Daily Briefing: A bad flu season gets worse
- Israel faces tough choices over haredi draft exemptions, legal expert warns
